-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Arch Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q2 2024.
- Arch Therapeutics, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $21.1K, a 13.8% increase year-over-year.
- Arch Therapeutics, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $89.5K, a 62.7% increase year-over-year.
- Arch Therapeutics, Inc. annual Cost of Revenue for 2023 was $78.2K, a 51.8% increase from 2022.
- Arch Therapeutics, Inc. annual Cost of Revenue for 2022 was $51.5K, a 95.9% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)